Reuters — The U.S. Food and Drug Administration on Friday moved to revoke approval of a drug used to treat certain conditions in pigs because it could leave a cancerous residue that may affect human health. The drug, carbadox, is made by Teaneck, N.J.-based Phibro Animal Health and is used to control swine dysentery and

U.S. to revoke pig drug approval over cancer risk concern

U.S. FDA to cut trans fats from foods
Washington/New York | Reuters –– The U.S. Food and Drug Administration on Tuesday made good on its proposal to effectively ban artificial trans fats from a wide range of foods, from microwave popcorn to frozen pizza, saying they raise the risk of heart disease. Under new FDA regulations, partially hydrogenated oils, which have been shown

U.S. proposes major update to food labels in bid to combat obesity
Under the new rules, serving sizes would reflect typical amount consumers eat
Packaged foods sold in the United States would display calorie counts more prominently and include the amount of added sugar under a proposal to significantly update nutritional labels for the first time in 20 years as health officials seek to reduce obesity and combat related diseases such as diabetes. The Food and Drug Administration said
U.S. FDA moves to ban trans fats, citing health risks
The U.S. Food and Drug Administration on Thursday proposed banning artificial trans fats in processed food ranging from cookies to frozen pizza, citing the risk of heart disease. Partially hydrogenated oils, the primary dietary source of the fats, have been shown to raise “bad” cholesterol. Reducing the use of trans fats could prevent 20,000 heart
Arsenic levels in rice too low for short-term risk: USDA
The U.S. Food and Drug Administration said Friday that after testing 1,300 samples of rice and rice products, it has determined the amount of detectable arsenic is too low to cause immediate or short-term negative health effects. The next step, the agency said, will be to conduct an analysis into the effects of long-term exposure
China pork plant purchase raises heart drug concerns
U.S. lawmakers are concerned a Chinese company’s planned $4.7 billion acquisition of pork producer Smithfield Foods Inc could affect the safety and availability of heparin, a blood-thinner derived from pig intestines and widely used in heart surgery and kidney dialysis. Members of the House Committee on Energy and Commerce wrote to Smithfield on July 24